论文部分内容阅读
近十年来,儿童急性淋巴细胞白血病的治疗有了显著进展。由于采用联合化学治疗的诱导缓解、维持治疗及中枢神经系统白血病的预防性治疗,中数生存期明显延长,并有约50%病例达到“治愈”。但慢性粒细胞白血病(简称慢粒)的治疗进展不大,治疗效果还不够满意,其中数生存期亦延长不多。不过,有关慢粒的基础知识发展很快,如:细胞遗传学分带
The past decade, the treatment of children with acute lymphoblastic leukemia has made significant progress. Median survival was significantly prolonged due to induction chemotherapy, maintenance therapy, and prophylactic treatment of CNS leukemia, and about 50% of cases were “cured.” However, the treatment of chronic myeloid leukemia (referred to as slow granules) progress is not large, the treatment effect is not enough, of which the number of survival is also not much extended. However, the basics of CML have developed rapidly, such as cytogenetic zoning